Relapse-Free Survival and PD-L1 Expression in First High- and Low-Grade Relapsed Luminal, Basal and Double-Negative P53-Mutant Non-Muscular Invasive Bladder Cancer Depending on Previous Chemo- and Immunotherapy
Екатерина Блинова(Sechenov University), Д. В. Перепечин, A.A. Kachmazov, Д. С. Блинов(Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology), Natalia V. Potoldykova(Sechenov University), Dmitry Enikeev(Chinese University of Hong Kong), Д С Меринов, Stanislav Serebrianyi, А. S. Tertychnyy(Sechenov University), Haydar Barakat(Peoples' Friendship University of Russia), E. A. Kogan(Sechenov University), Д А Рощин, Marina Dudina(Sechenov University), O. N. Deryabina(National Research Mordovia State University), Elena A. Samyshina
Cited by 8
Related Papers
Worldwide Distribution, Risk Factors, and Temporal Trends of Testicular Cancer Incidence and Mortality: A Global Analysis
|European Urology Oncology|2022|92
Therapeutic Potential and Main Methods of Obtaining Selenium Nanoparticles
|International Journal of Molecular Sciences|2021|85
Global Trends of Prostate Cancer by Age, and Their Associations With Gross Domestic Product (GDP), Human Development Index (HDI), Smoking, and Alcohol Drinking
|Clinical Genitourinary Cancer|2023|34